Cetuximab in the treatment of colorectal cancer

By Ciardiello Fortunato   De Vita Ferdinando   Orditura Michele   Comunale Daniela   Galizia Gennaro  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 173-181

Future Medicine

Access to resources Recommend Favorite

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1432-1438

Spandidos Publications

Access to resources Recommend Favorite

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

By Larsen Finn Ole   Pfeiffer Per   Nielsen Dorte   Skougaard Kristin   Qvortrup Camilla   Vistisen Kirsten   Fromm Anne-Lene   Jøørgensen Trine L.   Bjerregaard Jon K.   Hoegdall Estrid   Jensen Benny V.  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 574-577

Informa Healthcare

Access to resources Recommend Favorite

Colorectal Cancer in Elderly Patients: From Best Supportive Care to Cure

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 9, 2013-11 ,pp. : 1332-1343

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS

By Tural Deniz   Batur Sebnem   Erdamar Sibel   Akar Emre   Kepil Nuray   Mandel Nil   Serdengeçti Süheyla  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1041-1049

Springer Publishing Company

Access to resources Recommend Favorite